Mirati Therapeutics Inc (MRTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David D. Meek
Employees:
590
9393 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CA 92121
858-332-3410

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers. Sitravatinib, an investigational spectrum-selective kinase inhibitor, is in clinical trials for the treatment of NSCL cancer.

Data derived from most recent annual or quarterly report
Market Cap 2.553 Billion Shares Outstanding58.604 Million Avg 30-day Volume 1.458 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-3.18
Price to Revenue77.2877 Debt to Equity0.0 EBITDA-749.492 Million
Price to Book Value2.8862 Operating Margin-2862.6074 Enterprise Value1.32 Billion
Current Ratio5.85 EPS Growth-0.078 Quick Ratio5.643
1 Yr BETA 1.0748 52-week High/Low 101.3 / 27.3 Profit Margin-2709.3344
Operating Cash Flow Growth-20.2899 Free Cash Flow to Firm (FCFF) TTM -562.392 Million Free Cash Flow to Equity (FCFE) TTM-548.522 Million
Altman Z-Score0.7396
Earnings Report2023-11-08
View SEC Filings from MRTX instead.

View recent insider trading info

Mirati Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding MRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MRTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-09-12 by CHRISTENSEN JAMIE
  • 4: filed on 2023-09-12 by ONDREY AARON
  • 3: filed on 2023-09-12 by ONDREY AARON
  • 4: filed on 2023-08-15 by LEWIS JOSEPH
  • 4: filed on 2023-08-15 by LEWIS JOSEPH
  • 4: filed on 2023-08-10 by STELZER LAURIE
  • 4: filed on 2023-08-10 by BAUM CHARLES M
  • 4: filed on 2023-08-10 by HICKEY BENJAMIN
  • 4: filed on 2023-08-10 by CHRISTENSEN JAMIE
  • 4: filed on 2023-08-10 by SANDLER ALAN B.

    • Events (8k)

  • 8-K: filed on 2023-08-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-09:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-21:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-05-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-13:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    2.5 Million total shares from 5 transactions

    Open Market Sells (S)

    2.4 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    CHRISTENSEN JAMIE EVP & CHIEF SCIENTIFIC OFFICER

    • Officer
    		 144,032 2023-09-08 8

    ONDREY AARON INTERIM CFO

    • Officer
    		 14,028 2023-09-08 2

    BOXER CAPITAL, LLC

    BOXER ASSET MANAGEMENT INC.

    LEWIS JOSEPH

    MVA INVESTORS, LLC

    DAVIS AARON I.

    DISSANAYAKE SHEHAN BHARATHA

    FUGLESANG CHRISTOPHER

    • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
    		 6,672,789 2023-08-11 2

    HASNAIN FAHEEM

    • Director
    		 25,841 2023-08-11 2

    MORIARTY JOHN B CHIEF LEGAL OFFICER

    • Officer
    		 71,660 2023-08-09 2

    BAUM CHARLES M INTERIM CEO

    • Officer
    • Director
    		 227,275 2023-08-09 5

    STELZER LAURIE CHIEF FINANCIAL OFFICER

    • Officer
    		 102,312 2023-08-09 3

    HICKEY BENJAMIN EVP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 105,914 2023-08-09 5

    SANDLER ALAN B. CHIEF MEDICAL OFFICER

    • Officer
    		 62,297 2023-08-09 3

    GALLAGHER CAROL GILTNER

    • Director
    		 7,555 2023-06-22 2

    FUCHS HENRY J

    • Director
    		 17,985 2023-01-20 1

    CARTER BRUCE L A

    • Director
    		 17,985 2023-01-20 1

    JOHNSON CRAIG A

    • Director
    		 17,985 2023-01-20 1

    SHARP SHALINI

    • Director
    		 16,934 2023-01-20 1

    DAVIS AARON I.

    • Director
    • 10% Owner
    		 55,037 2023-01-20 1

    MEEK DAVID D. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 302,404 2023-01-20 3

    MARTINEZ MARIA E

    • Director
    		 17,985 2023-01-20 1

    CHERRINGTON JULIE M

    • Director
    		 11,964 2023-01-20 2

    REED VICKIE S SVP, CHIEF ACCOUNTING OFFICER

    • Officer
    		 40,181 2022-01-14 0

    BRASLYN LTD.

    LEWIS JOSEPH

    • 10% Owner
    		 6,714,006 2021-03-09 2

    BOXER CAPITAL, LLC

    BOXER ASSET MANAGEMENT INC.

    LEWIS JOSEPH

    MVA INVESTORS, LLC

    DAVIS AARON I.

    LIEBERBURG IVAN M

    DISSANAYAKE SHEHAN BHARATHA

    FUGLESANG CHRISTOPHER

    • 10% Owner
    		 2,563,142 2021-03-05 2

    FAGA DANIEL EVP, CHIEF OPERATING OFFICER

    • Officer
    		 94,268 2021-02-02 0

    GREY MICHAEL G

    • Director
    		 7,886 2021-01-15 0

    LOCKEND FIVE, LLC

    • 10% Owner
    		 203,754 2020-10-28 0

    BRASLYN LTD.

    • 10% Owner
    		 3,135,966 2020-06-12 0

    CHEN ISAN EVP, CHIEF MEDICAL OFFICER

    • Officer
    		 62,821 2020-05-11 0

    BOXER CAPITAL, LLC

    • 10% Owner
    		 1,765,560 2020-01-10 0

    AVORO CAPITAL ADVISORS LLC

    AGHAZADEH BEHZAD

    • 10% Owner
    		 No longer subject to file 2019-07-23 0

    MVA INVESTORS, LLC

    • 10% Owner
    		 253,338 2019-07-11 0

    DONADIO JAMIE A SR. VP, CFO

    • Officer
    		 13,346 2019-05-16 0

    REISMAN NEIL

    • 10% Owner
    		 87,607 2019-04-04 0

    DISSANAYAKE SHEHAN BHARATHA

    • 10% Owner
    		 203,754 2019-04-04 0

    LEMASTERS CHRISTOPHER C. EVP, CHIEF BUSINESS OFFICER

    • Officer
    		 60,000 2019-02-14 0

    LAPPE RODNEY W

    • Director
    • 10% Owner
    		 11,000 2019-01-17 0

    BOXER CAPITAL, LLC

    BOXER ASSET MANAGEMENT INC.

    LEWIS JOSEPH

    • 10% Owner
    		 1,565,560 2018-06-07 0

    BAKER BROS. ADVISORS LP

    BAKER BROS. ADVISORS (GP) LLC

    BAKER FELIX

    BAKER JULIAN

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2017-11-16 0

    BOXER CAPITAL, LLC

    BRASLYN LTD.

    • 10% Owner
    		 6,723,399 2017-11-16 0

    BROADFIN HEALTHCARE MASTER FUND LTD

    BROADFIN CAPITAL, LLC

    KOTLER KEVIN

    • 10% Owner
    		 No longer subject to file 2017-11-16 0

    BOXER CAPITAL, LLC

    BRASLYN LTD.

    LEWIS JOSEPH

    FUGLESANG CHRISTOPHER

    LAPPE RODNEY W

    LIEBERBURG IVAN M

    REISMAN NEIL

    DISSANAYAKE SHEHAN BHARATHA

    DAVIS AARON I.

    MVA INVESTORS, LLC

    • Director
    • 10% Owner
    		 513,630 2017-10-03 0

    BOXER CAPITAL, LLC

    BOXER ASSET MANAGEMENT INC.

    • 10% Owner
    		 513,630 2017-10-03 0

    TUESDAY THIRTEEN INC.

    • 10% Owner
    		 0 2017-09-21 0

    BOXER CAPITAL, LLC

    LEWIS JOSEPH

    BOXER ASSET MANAGEMENT INC.

    MVA INVESTORS, LLC

    LAPPE RODNEY W

    LIEBERBURG IVAN M

    DAVIS AARON I.

    REISMAN NEIL

    DISSANAYAKE SHEHAN BHARATHA

    FUGLESANG CHRISTOPHER

    • 10% Owner
    		 4,111,251 2017-01-06 0

    RINGO WILLIAM R

    • Director
    		 0 2016-05-18 0

    BOXER ASSET MANAGEMENT INC.

    • 10% Owner
    		 757,935 2016-03-17 0

    GERGEN MARK J EXECUTIVE VP, COO

    • Officer
    		 0 2016-01-22 0

    LIEBERBURG IVAN M

    • 10% Owner
    		 1,684,093 2016-01-14 0

    FUGLESANG CHRISTOPHER

    • 10% Owner
    		 1,680,515 2016-01-14 0

    HARWIN PETER EVAN

    • 10% Owner
    		 1,665,024 2016-01-14 0

    WILLIAM N. HARWIN 2012 GIFT TRUST F/B/O PETER HARWIN

    • 10% Owner
    		 1,232,984 2016-01-14 0

    BRASLYN LTD.

    BOXER ASSET MANAGEMENT INC.

    LEWIS JOSEPH

    BOXER CAPITAL, LLC

    MVA INVESTORS, LLC

    BERKLEY CAPITAL MANAGEMENT LTD.

    • 10% Owner
    		 2,975,072 2016-01-04 0

    BOXER CAPITAL, LLC

    BOXER ASSET MANAGEMENT INC.

    LEWIS JOSEPH

    BERKLEY CAPITAL MANAGEMENT LTD.

    MVA INVESTORS, LLC

    • 10% Owner
    		 2,975,072 2015-09-16 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP IV LLC

    ISALY SAMUEL D

    • 10% Owner
    		 No longer subject to file 2015-02-03 0

    BAKER BROS. ADVISORS LP

    BAKER FELIX

    BAKER JULIAN

    BAKER BROS. ADVISORS (GP) LLC

    BAKER BROTHERS LIFE SCIENCES LP

    667, L.P.

    • 10% Owner
    		 2,805,074 2015-01-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    ONDREY AARON - Officer INTERIM CFO

    		2023-09-12 17:30:32 -0400 2023-09-08 A 8,412 $35.66 a 22,440 direct -2.9662 -4.5815 0.0 1 -6.5786 4

    CHRISTENSEN JAMIE - Officer EVP & CHIEF SCIENTIFIC OFFICER

    		2023-09-12 17:41:29 -0400 2023-09-08 S 2,388 $35.63 d 144,032 direct -2.9662 -4.5815 0.0 1 -6.5786 4

    HASNAIN FAHEEM - Director by hasnain revocable trust dated 2-19-2010

    		2023-08-14 16:41:20 -0400 2023-08-11 P 10,791 $27.80 a 10,791 indirect -0.0252 -5.2102 3.7755 4.0775 29 -19.9346 24

    BOXER CAPITAL, LLC SEE REMARKS see footnote

    BOXER ASSET MANAGEMENT INC. SEE REMARKS see footnote

    LEWIS JOSEPH SEE REMARKS see footnote

    MVA INVESTORS, LLC SEE REMARKS see footnote

    DAVIS AARON I. SEE REMARKS see footnote

    DISSANAYAKE SHEHAN BHARATHA SEE REMARKS see footnote

    FUGLESANG CHRISTOPHER SEE REMARKS see footnote

    		2023-08-15 21:38:44 -0400 2023-08-11 P 57,533 $27.80 a 287,866 indirect -1.6868 -5.4632 14.1742 14.1742 31 -19.9144 23

    BOXER CAPITAL, LLC SEE REMARKS

    BOXER ASSET MANAGEMENT INC. SEE REMARKS

    LEWIS JOSEPH SEE REMARKS

    MVA INVESTORS, LLC SEE REMARKS

    DAVIS AARON I. SEE REMARKS

    DISSANAYAKE SHEHAN BHARATHA SEE REMARKS

    FUGLESANG CHRISTOPHER SEE REMARKS

    		2023-08-15 21:38:44 -0400 2023-08-11 P 1,201,440 $27.80 a 3,201,440 direct -1.6868 -5.4632 14.1742 14.1742 31 -19.9144 23

    BOXER CAPITAL, LLC SEE REMARKS see footnote

    BOXER ASSET MANAGEMENT INC. SEE REMARKS see footnote

    LEWIS JOSEPH SEE REMARKS see footnote

    MVA INVESTORS, LLC SEE REMARKS see footnote

    DAVIS AARON I. SEE REMARKS see footnote

    DISSANAYAKE SHEHAN BHARATHA SEE REMARKS see footnote

    FUGLESANG CHRISTOPHER SEE REMARKS see footnote

    		2023-08-15 21:39:22 -0400 2023-08-11 P 57,533 $27.80 a 287,866 indirect -1.6868 -5.4632 14.1742 14.1742 31 -19.9144 23

    BOXER CAPITAL, LLC SEE REMARKS

    BOXER ASSET MANAGEMENT INC. SEE REMARKS

    LEWIS JOSEPH SEE REMARKS

    MVA INVESTORS, LLC SEE REMARKS

    DAVIS AARON I. SEE REMARKS

    DISSANAYAKE SHEHAN BHARATHA SEE REMARKS

    FUGLESANG CHRISTOPHER SEE REMARKS

    		2023-08-15 21:39:22 -0400 2023-08-11 P 1,201,440 $27.80 a 3,201,440 direct -1.6868 -5.4632 14.1742 14.1742 31 -19.9144 23

    SANDLER ALAN B. - Officer CHIEF MEDICAL OFFICER

    		2023-08-10 16:19:57 -0400 2023-08-09 A 22,297 $37.00 a 62,297 direct 2.9632 -0.5669 6.5447 6.5447 31 -18.0366 26

    BAUM CHARLES M - Director - Officer INTERIM CEO

    		2023-08-10 16:24:44 -0400 2023-08-09 A 54,054 $37.00 a 227,275 direct 2.9632 -0.5669 6.5447 6.5447 31 -18.0366 26

    HICKEY BENJAMIN - Officer EVP, CHIEF COMMERCIAL OFFICER

    		2023-08-10 16:23:46 -0400 2023-08-09 A 22,297 $37.00 a 105,914 direct 2.9632 -0.5669 6.5447 6.5447 31 -18.0366 26

    MORIARTY JOHN B - Officer CHIEF LEGAL OFFICER

    		2023-08-10 16:22:43 -0400 2023-08-09 A 22,297 $37.00 a 71,660 direct 2.9632 -0.5669 6.5447 6.5447 31 -18.0366 26

    CHRISTENSEN JAMIE - Officer EVP & CHIEF SCIENTIFIC OFFICER

    		2023-08-10 16:21:09 -0400 2023-08-09 A 22,297 $37.00 a 146,420 direct 2.9632 -0.5669 6.5447 6.5447 31 -18.0366 26

    STELZER LAURIE - Officer CHIEF FINANCIAL OFFICER

    		2023-08-10 16:26:35 -0400 2023-08-09 A 22,297 $37.00 a 102,312 direct 2.9632 -0.5669 6.5447 6.5447 31 -18.0366 26

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 22:15:03 UTC 5.0626 0.2574 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 21:45:03 UTC 5.0626 0.2574 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 21:15:04 UTC 5.0626 0.2574 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 20:45:04 UTC 5.0626 0.2574 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 20:15:03 UTC 5.0622 0.2578 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 19:45:03 UTC 5.0622 0.2578 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 19:15:03 UTC 5.0622 0.2578 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 18:45:04 UTC 5.0643 0.2557 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 18:15:04 UTC 5.0643 0.2557 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 17:45:04 UTC 5.064 0.256 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 17:15:03 UTC 5.064 0.256 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 16:45:04 UTC 5.064 0.256 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 16:15:04 UTC 5.064 0.256 750000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 15:45:04 UTC 5.064 0.256 700000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 15:15:04 UTC 5.064 0.256 700000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 14:45:03 UTC 5.0363 0.2837 700000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 14:15:03 UTC 5.0363 0.2837 700000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 13:45:04 UTC 5.0663 0.2537 700000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 13:15:05 UTC 5.0663 0.2537 700000
    MIRATI THERAPEUTICS INC MRTX 2023-10-02 12:45:05 UTC 5.0663 0.2537 550000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund MRTX -702.0 shares, $-90459.72 2019-12-31 N-PORT
    Advisors Series Trust- Pzena Long/Short Value Fund MRTX -1272.0 shares, $-126169.68 2020-05-31 N-PORT
    Trust for Professional Managers- Convergence Market Neutral Fund MRTX -495.0 shares, $-73938.15 2020-08-31 N-PORT
    FundVantage Trust- Gotham Enhanced Index Plus Fund MRTX -30.0 shares, $-2306.1 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund MRTX -12.0 shares, $-922.44 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund MRTX -67.0 shares, $-5150.29 2020-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund MRTX -830.0 shares, $-142179.0 2021-03-31 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity Fund MRTX -448.0 shares, $-61272.96 2021-11-30 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund MRTX -120.0 shares, $-5437.2 2022-12-30 N-PORT
    VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND MRTX -1511.0 shares, $-80702.51 2023-01-31 N-PORT
    RBB Fund, Inc.- Boston Partners Long/Short Research Fund MRTX -7301.0 shares, $-271305.16 2023-05-31 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity ETF MRTX -1611.0 shares, $-59864.76 2023-05-31 N-PORT
    Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund MRTX -7303.0 shares, $-263857.39 2023-06-30 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund MRTX -6158.0 shares, $-222488.54 2023-06-30 N-PORT
    AQR Funds- AQR Multi-Asset Fund MRTX -6404.0 shares, $-231376.52 2023-06-30 N-PORT
    TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund MRTX -7937.0 shares, $-286763.81 2023-06-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund MRTX -700.0 shares, $-25291.0 2023-06-30 N-PORT
    Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund MRTX -1236.0 shares, $-37413.72 2023-07-31 N-PORT
    ALLSPRING FUNDS TRUST- Allspring U.S. Long/Short Equity Fund MRTX -1046.0 shares, $-31662.42 2023-07-31 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    Hon. Daniel Goldman House Filing 2023-05-03 2023-04-10 S $1,001-$15,000
    Hon. Daniel Goldman House Filing 2023-04-03 2023-03-06 P $1,001-$15,000
    WhaleWisdom Logo

    Elevate your investments